UPDATE - SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of ...
CLEVELAND, May 14, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics announced the publication of a multicenter double-blind randomized, placebo-controlled trial of individuals experiencing moderate-to-severe postoperative pain following knee replacement and treatment
Source: eagletribune.com